A Phase I Open-Label Multicenter Study to Evaluate the Safety Tolerability Pharmacodynamics and Pharmacokinetics of Calcipotriene Foam 0.005% Applied Under Maximal-Use Conditions in Adolescent Subjects (Ages 12 to 16 Years) with Plaque Psoriasis
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to test the safety of calcipotriene when treating adolescent children for plaque psoriasis.
Description
The purpose of this study is to test the safety of calcipotriene when treating adolescent children for plaque psoriasis.
Details
| Condition | Plaque Psoriasis |
|---|---|
| Age | 12years - 16years |
| Clinical Study Identifier | TX3936 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.